![ClinRheumatol Profile](https://pbs.twimg.com/profile_images/1161271875466661888/oYEcGVNi_x96.png)
ClinRheumatol
@ClinRheumatol
Followers
8K
Following
219
Statuses
762
Clinical Rheumatology - Journal of the International League of Associations for Rheumatology 2023 Impact Factor: 2.9 Editor-in-Chief: Prof. Adewale Adebajo
Joined August 2019
Late-onset #AxialSpondyloarthritis #AxSpA: data from Reuma-check cohort by @RodrigoGSalinas and colleagues @sofiaramiro82 π
Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? π π Key findings from the Reuma-check cohort: βοΈ 28% of axSpA cases started at β₯45 years. βοΈ More common in females (51%) & psoriasis (42%). βοΈ Lower NSAID response (52%) & HLA-B27 positivity (32%). βοΈ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA β οΈ lo-axSpA may require distinct diagnostic & treatment approaches.
0
3
9
Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? π π Key findings from the Reuma-check cohort: βοΈ 28% of axSpA cases started at β₯45 years. βοΈ More common in females (51%) & psoriasis (42%). βοΈ Lower NSAID response (52%) & HLA-B27 positivity (32%). βοΈ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA β οΈ lo-axSpA may require distinct diagnostic & treatment approaches.
0
21
49
How do ILAR & PRINTO classifications impact #JIA diagnosis and treatment? π β
Age & ANA positivity (β₯1/160) improve consistency in assessing uveitis risk & treatment response β
One positive ANA test may be enoughβno need for repeat testing β
Early bDMARDs treatment may benefit ANA-positive JIA patients β
PRINTOβs βother JIAβ category needs further refinement for clinical use
0
5
10
π’ New Review on Ectopic Calcifications in the Musculoskeletal Field β
Mechanisms of soft-tissue calcifications β
Pharmacological strategies: NSAIDs, corticosteroids, bisphosphonates, vitamin K2+D β
Balancing #calcification inhibition with bone health π
0
5
9
Refractory #PsoriaticArthritis #PsA: π Lack of consensus on definition. β
Authors propose two categories: πD2T PsA: persistent despite treatment. πPseudo-D2T PsA: misdiagnosis or mismanagement. Clear distinctions can improve care! π
0
13
22
π₯NEWπ₯ Refractory #PsoriaticArthritis: emerging concepts in whole process management π πPhases of #PsA development and strategies for prevention π
0
22
38
π₯New Editorial to read! π Explore strategies for tailored #PatientEducation to boost adherence, improve outcomes, and tackle challenges in biologic therapy. #biologics #rheumatology
0
8
11
New Study Highlights Urgent Need for #Rheumatology #Education in Medical Schools. π Teaching hours: 4β120 globally π Limited exposure impacts awareness & recruitment π Standardized curricula needed for rising rheumatic disease burden
0
4
17
π Thank you to our readers, authors, and reviewers for your invaluable contributions this year. Your dedication helps us advance the field of #rheumatology and improve patient care worldwide. Wishing you a joyful holiday season and a successful New Year! πβοΈπ
0
4
20
π₯ Can diet impact #RheumatoidArthritis? π₯© New study finds: β
A low-carbohydrate diet (LCD) may reduce #RA risk. β
High protein intake is linked to a lower likelihood of RA. π #Diet
0
7
18
#Frailty and pre-frailty are common in #SystemicSclerosis #SSc πΉ 14% frail, 53% pre-frail πΉ β risk of mortality, β quality of life πΉ Key drivers: cardiopulmonary disease, inflammation & age πEarly detection & intervention could change outcomesπ
0
6
6
Letβs harness #AI responsibly to advance knowledge while protecting the integrity of #science! This editorial discusses β
Ethical integration of tools like #ChatGPT into #research β
Transparency as a cornerstone of scientific integrity β
The REFINE process: Review, Evaluate, Formulate, Improve, Nuance, Enhance
0
6
11
π₯New insights on #BotulinumToxin for #RaynaudsPhenomenon secondary to #Scleroderma! The systematic review reveals significant pain relief & functional improvement π More research is needed to standardize doses & techniques. π
1
13
36